For selection purposes, during zebrafish embryo infection experiments, C. turicensis LMG 23827T_ΔrpfF/pCCR9 as well as C. turicensis LMG 23827T_ΔrpfR/pCCR9 were constructed by transformation of the strains with the vector using standard methods.
Strains were grown in Luria–Bertani (LB) broth over night at 37 °C with gentle shaking. Where appropriate, culture medium or agar was supplemented with nalidixic acid at 256 mg L−1 (C. turicensis LMG 23827T_NalR), chloramphenicol at 30 mg L−1 (strains harbouring pDS132) or both (transconjugant strains) or tetracyclin at 50 mg L−1 (strains harbouring pCCR9 or pRZT3::dsRed).
For microinjection experiments, the bacteria were harvested by centrifugation at 5000 × g for 10 min and washed once in 10 ml of Dubelcco’s phosphate buffered saline (DPBS, Life Technologies, Switzerland.) After a second centrifugation step, the cells were resuspended in DPBS, and appropriate dilutions were prepared in DPBS.